Akari Therapeutics PLC (AKTX)
1.19
-0.02
(-1.65%)
USD |
NASDAQ |
Apr 24, 16:00
1.17
-0.02
(-1.68%)
After-Hours: 20:00
Akari Therapeutics Shareholders Equity (Quarterly): -0.229M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.229M |
| June 30, 2023 | 2.782M |
| June 30, 2022 | 8.326M |
| March 31, 2022 | 13.93M |
| Date | Value |
|---|---|
| December 31, 2021 | 5.555M |
| September 30, 2021 | 11.36M |
| June 30, 2021 | 1.588M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.229M
Minimum
Dec 2023
13.93M
Maximum
Mar 2022
6.188M
Average
5.555M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| DBV Technologies SA | 140.19M |
| Adaptimmune Therapeutics PLC | 39.51M |
| Biodexa Pharmaceuticals Plc | 5.959M |
| NuCana PLC | 18.96M |
| Genfit SA | 75.11M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.355M |
| Total Liabilities (Quarterly) | 4.584M |